NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

Home・Lista de Ações・Coloplast A-S (Class B)

Coloplast A-S (Class B)

Fechado

400 -0.57

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

399.1

Máximo

403.7

Indicadores-chave
By Trading Economics
Rendimento	522M 1.4B
Vendas	83M 7B
P/E Médio do Setor	23.047 49.8
EPS	6.32
Rendimento de Dividendos	5.71
Margem de lucro	19.835
Funcionários	16,983
EBITDA	309M 2.3B

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+11.86% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	5.71% 2.25%
Próximos Ganhos	12 de mai. de 2026
Próxima data de dividendos	20 de mai. de 2026
Próxima data de ex-dividendo	18 de mai. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-27B 92B
Abertura anterior	400.57
Fecho anterior	400

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Gold Falls on Renewed Inflation Concerns -- Market Talk

10 de mai. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

10 de mai. de 2026, 23:38 UTC

Conversa de Mercado

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

10 de mai. de 2026, 23:14 UTC

Conversa de Mercado

Australia's Political Map Continues to Be Redrawn -- Market Talk

10 de mai. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Elevra Lithium: Expects Deal to Close in 1Q FY27

10 de mai. de 2026, 22:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

10 de mai. de 2026, 22:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

10 de mai. de 2026, 10:21 UTC

Ganhos

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

9 de mai. de 2026, 06:05 UTC

Ganhos

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

8 de mai. de 2026, 23:55 UTC

Ganhos

Review & Preview: Still Going Strong -- Barrons.com

8 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de mai. de 2026, 20:49 UTC

Ganhos

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

8 de mai. de 2026, 20:25 UTC

Ganhos

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 de mai. de 2026, 19:43 UTC

Ganhos

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

8 de mai. de 2026, 19:43 UTC

Ganhos

Cencosud 1Q Net $115M

8 de mai. de 2026, 19:20 UTC

Conversa de Mercado

Oil Futures End Session Higher, But Down on the Week -- Market Talk

8 de mai. de 2026, 19:18 UTC

Ganhos

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

8 de mai. de 2026, 19:16 UTC

Ganhos

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 de mai. de 2026, 19:08 UTC

Ganhos

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 de mai. de 2026, 19:05 UTC

Ganhos

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

8 de mai. de 2026, 19:02 UTC

Conversa de Mercado

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

8 de mai. de 2026, 18:51 UTC

Ganhos

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

8 de mai. de 2026, 18:49 UTC

Ganhos

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 de mai. de 2026, 18:41 UTC

Ganhos

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

8 de mai. de 2026, 17:38 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

8 de mai. de 2026, 17:14 UTC

Ganhos

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

8 de mai. de 2026, 17:04 UTC

Conversa de Mercado

Zcash Caps Off Parabolic Week -- Market Talk

8 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

8 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de mai. de 2026, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK 11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

Comprar

Manter

Vender

Com base em 8 analistas que deram avaliações de ações para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.